These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38923999)

  • 41. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis.
    Armartmuntree N; Murata M; Techasen A; Yongvanit P; Loilome W; Namwat N; Pairojkul C; Sakonsinsiri C; Pinlaor S; Thanan R
    Redox Biol; 2018 Apr; 14():637-644. PubMed ID: 29169115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
    Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S
    BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhancement of gemcitabine sensitivity in intrahepatic cholangiocarcinoma through Saikosaponin-a mediated modulation of the p-AKT/BCL-6/ABCA1 axis.
    Song F; Wang CG; Wang TL; Tao YC; Mao JZ; Hu CW; Zhang Y; Tang PJ; Lu CL; Qing HL; Han L; Chen Z
    Phytomedicine; 2024 Oct; 133():155944. PubMed ID: 39146879
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Galangin Inhibits Cholangiocarcinoma Cell Growth and Metastasis through Downregulation of MicroRNA-21 Expression.
    Zou Y; Li R; Kuang D; Zuo M; Li W; Tong W; Jiang L; Zhou M; Chen Y; Gong W; Liu L; Tou F
    Biomed Res Int; 2020; 2020():5846938. PubMed ID: 32626749
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.
    Zhang H; Li Z; Chu B; Zhang F; Zhang Y; Ke F; Chen Y; Xu Y; Liu S; Zhao S; Liang H; Weng M; Wu X; Li M; Wu W; Quan Z; Liu Y; Zhang Y; Gong W
    Tumour Biol; 2016 Jun; 37(6):8305-15. PubMed ID: 26729195
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Perturbation of proteasome function by bortezomib leading to ER stress-induced apoptotic cell death in cholangiocarcinoma.
    Vaeteewoottacharn K; Kariya R; Matsuda K; Taura M; Wongkham C; Wongkham S; Okada S
    J Cancer Res Clin Oncol; 2013 Sep; 139(9):1551-62. PubMed ID: 23877657
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular mechanism of Spatholobi Caulis treatment for cholangiocarcinoma based on network pharmacology, molecular docking, and molecular dynamics simulation.
    Chen X; Sun B; Zeng J; Yu Z; Liu J; Tan Z; Li Y; Peng C
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Aug; 397(8):5789-5806. PubMed ID: 38321212
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of NF-κB Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells.
    Seubwai W; Vaeteewoottacharn K; Kraiklang R; Umezawa K; Okada S; Wongkham S
    Oncol Res; 2016 Jan; 23(1-2):21-8. PubMed ID: 26802647
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MRP3-Mediated Chemoresistance in Cholangiocarcinoma: Target for Chemosensitization Through Restoring SOX17 Expression.
    Lozano E; Asensio M; Perez-Silva L; Banales JM; Briz O; Marin JJG
    Hepatology; 2020 Sep; 72(3):949-964. PubMed ID: 31863486
    [TBL] [Abstract][Full Text] [Related]  

  • 50. LncRNA FENDRR represses proliferation, migration and invasion through suppression of survivin in cholangiocarcinoma cells.
    Qin X; Lu M; Zhou Y; Li G; Liu Z
    Cell Cycle; 2019 Apr; 18(8):889-897. PubMed ID: 30983519
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suppression of trophoblast cell surface antigen 2 enhances proliferation and migration in liver fluke-associated cholangiocarcinoma.
    Sawanyawisuth K; Tantapotinan N; Wongkham C; Riggins GJ; Kraiklang R; Wongkham S; Puapairoj A
    Ann Hepatol; 2016; 15(1):71-81. PubMed ID: 26626643
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lobaplatin induces apoptosis and arrests cell cycle progression in human cholangiocarcinoma cell line RBE.
    Wang Z; Tang X; Zhang Y; Qi R; Li Z; Zhang K; Liu Z; Yang X
    Biomed Pharmacother; 2012 Apr; 66(3):161-6. PubMed ID: 22425181
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Actinidia arguta (Hardy Kiwi) Root Extract Exerts Anti-cancer Effects via Mcl-1-Mediated Apoptosis in Cholangiocarcinoma.
    Zhao X; Wen F; Wang W; Lu Z; Guo Q
    Nutr Cancer; 2019; 71(2):246-256. PubMed ID: 30633583
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cordycepin Inhibits Cancer Cell Proliferation and Angiogenesis through a DEK Interaction via ERK Signaling in Cholangiocarcinoma.
    Liu T; Zhu G; Yan W; Lv Y; Wang X; Jin G; Cui M; Lin Z; Ren X
    J Pharmacol Exp Ther; 2020 May; 373(2):279-289. PubMed ID: 32102917
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of apoptotic cell death of cholangiocarcinoma cells by tiliacorinine from Tiliacora triandra: A mechanistic insight.
    Detarya M; Mahalapbutr P; Waenphimai O; Kidoikhammouan S; Janeklang S; Sawanyawisuth K; Vaeteewoottacharn K; Seubwai W; Saengboonmee C; Thothaisong T; Pabuprapap W; Suksamrarn A; Wongkham S
    Biochim Biophys Acta Gen Subj; 2023 Dec; 1867(12):130486. PubMed ID: 37813201
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Corilagin suppresses cholangiocarcinoma progression through Notch signaling pathway in vitro and in vivo.
    Gu Y; Xiao L; Ming Y; Zheng Z; Li W
    Int J Oncol; 2016 May; 48(5):1868-76. PubMed ID: 26935808
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In Silico Target Identification of Galangin, as an Herbal Flavonoid against Cholangiocarcinoma.
    Balasubramanian B; Venkatraman S; Myint KZ; Krobthong S; Wongtrakoongate P; Sripa J; Rattanasinganchan P; Metheenukul P; Tohtong R
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889537
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma.
    Hu MH; Huang TT; Chao TI; Chen LJ; Chen YL; Tsai MH; Liu CY; Kao JH; Chen KF
    Liver Int; 2018 Dec; 38(12):2248-2259. PubMed ID: 29797403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methylthioadenosine (MTA) inhibits melanoma cell proliferation and in vivo tumor growth.
    Andreu-Pérez P; Hernandez-Losa J; Moliné T; Gil R; Grueso J; Pujol A; Cortés J; Avila MA; Recio JA
    BMC Cancer; 2010 Jun; 10():265. PubMed ID: 20529342
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined Gemcitabine and Metronidazole Is a Promising Therapeutic Strategy for Cancer Stem-like Cholangiocarcinoma.
    Kawamoto M; Umebayashi M; Tanaka H; Koya N; Nakagawa S; Kawabe K; Onishi H; Nakamura M; Morisaki T
    Anticancer Res; 2018 May; 38(5):2739-2748. PubMed ID: 29715094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.